REGULATED PRESS RELEASE published on 06/11/2024 at 08:00, 3 months 9 days ago EURAZEO, THE MANAGEMENT TEAM OF I-TRACING AND SAGARD NEWGEN HAVE ENTERED INTO EXCLUSIVE DISCUSSIONS TO WELCOME OAKLEY CAPITAL AS A REFERENCE SHAREHOLDER OF THE GROUP Eurazeo, I-TRACING management team, and Sagard NewGen are in talks to welcome Oakley Capital as reference shareholder, aiming to boost I-TRACING's growth in cybersecurity services EURAZEO Cybersecurity Services Oakley Capital I-Tracing Sagard NewGen
REGULATED PRESS RELEASE published on 06/11/2024 at 08:00, 3 months 9 days ago EURAZEO, L’EQUIPE DE MANAGEMENT D’I-TRACING ET SAGARD NEWGEN ENTRENT EN DISCUSSIONS EXCLUSIVES EN VUE D’ACCUEILLIR OAKLEY CAPITAL COMME NOUVEL ACTIONNAIRE DE REFERENCE DU GROUPE Eurazeo, l'\xe9quipe de management d'I-Tracing et Sagard NewGen entrent en discussions exclusives pour accueillir Oakley Capital comme nouvel actionnaire de r\xe9f\xe9rence du groupe EURAZEO Oakley Capital I-Tracing Sagard NewGen Cybers\xe9curit\xe9
REGULATED PRESS RELEASE published on 06/10/2024 at 17:35, 3 months 9 days ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 juin 2024
REGULATED PRESS RELEASE published on 06/10/2024 at 17:35, 3 months 9 days ago Disclosure of transactions in own shares on June 3 to June 7, 2024
BRIEF published on 06/07/2024 at 17:40, 3 months 12 days ago EURAZEO : Nombre d'actions et droits de vote au 31 mai 2024 Droits De Vote Capital Social Actions EURAZEO AMF
BRIEF published on 06/07/2024 at 17:40, 3 months 12 days ago Disclosure of EURAZEO's Shares and Voting Rights as of May 31, 2024 Voting Rights Shares EURAZEO Financial Disclosure AMF Regulation
REGULATED PRESS RELEASE published on 06/07/2024 at 17:35, 3 months 12 days ago Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 31 mai 2024 Le groupe Eurazeo publie le nombre d'actions et de droits de vote au 31 mai 2024, conformément à la réglementation financière. Eurazeo est un investisseur majeur avec 35,0 milliards d'euros d'actifs diversifiés Investissement Déclaration Droits De Vote Capital Social EURAZEO
REGULATED PRESS RELEASE published on 06/07/2024 at 17:35, 3 months 12 days ago Disclosure of the number of shares and the total number of voting rights as of May 31, 2024 Disclosure of the number of shares and the total number of voting rights for EURAZEO SE as of May 31, 2024 in compliance with regulations. Eurazeo is a leading European investment group managing diversified assets Voting Rights Shares Investment Group Regulations Eurazeo SE
BRIEF published on 06/06/2024 at 17:50, 3 months 13 days ago Eurazeo : Grape Hospitality signe un accord pour céder 23 hôtels Stratégie EURAZEO Immobilier Grape Hospitality Cession D'hôtels
BRIEF published on 06/06/2024 at 17:50, 3 months 13 days ago Eurazeo Announces Grape Hospitality’s Exclusive Agreement for the Sale of 23 Hotels Real Estate EURAZEO Investment Hotel Sale Grape Hospitality
Published on 09/20/2024 at 13:00, 29 minutes ago Aston Bay and American West Metals Thick High-Grade Copper in Deep Drilling at the Storm Project, Nunavut, Canada
Published on 09/20/2024 at 09:05, 4 hours 24 minutes ago Nano One Closes on $5 Million Sale of Vacant Land
Published on 09/20/2024 at 02:00, 11 hours 29 minutes ago Academy of Math and Science Celebrates Hispanic Heritage Month
Published on 09/19/2024 at 23:15, 14 hours 14 minutes ago Cypher Metaverse Inc. Announces Second Closing of Financing
Published on 09/20/2024 at 13:00, 29 minutes ago Le salon de l’eau, de l’énergie, de la technologie et de l’environnement (WETEX) 2024 présente les tendances d’avant-garde en matière de santé et de sécurité à domicile et sur le lieu de travail
Published on 09/20/2024 at 11:44, 1 hour 45 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 09/20/2024 at 11:20, 2 hours 9 minutes ago Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Published on 09/20/2024 at 11:14, 2 hours 15 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: RBI signs agreement on the sale of Priorbank JSC to Soven 1 Holding Limited
Published on 09/20/2024 at 08:45, 4 hours 44 minutes ago BAIKOWSKI : Rapport financier semestriel 2024
Published on 09/20/2024 at 08:00, 5 hours 29 minutes ago MEDESIS PHARMA : Résultats encourageants de la première phase de l’essai clinique de phase 2a pour le traitement de la maladie d’Alzheimer avec le NanoLIthium